Medicaid prescriptions for GLP-1s increased from about 1 million in 2019 to over 8 million in 2024, according to KFF
Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste
Is Reta Peptide Safe
That's up for grabs, but let's put it this way
Their review, however, found that most of the evidence of such health effects was from rodent studies , and only three small pilot studies had looked at BPC-157 use in humans
The specific condition or reason for undergoing IV therapy may dictate the duration of the treatment